281 related articles for article (PubMed ID: 29981000)
1. CCR2 on Peripheral Blood CD14
Veenstra M; Byrd DA; Inglese M; Buyukturkoglu K; Williams DW; Fleysher L; Li M; Gama L; León-Rivera R; Calderon TM; Clements JE; Morgello S; Berman JW
J Neuroimmune Pharmacol; 2019 Mar; 14(1):120-133. PubMed ID: 29981000
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of CNS Viral Seeding by HIV
Veenstra M; León-Rivera R; Li M; Gama L; Clements JE; Berman JW
mBio; 2017 Oct; 8(5):. PubMed ID: 29066542
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of HIV entry into the CNS: increased sensitivity of HIV infected CD14+CD16+ monocytes to CCL2 and key roles of CCR2, JAM-A, and ALCAM in diapedesis.
Williams DW; Calderon TM; Lopez L; Carvallo-Torres L; Gaskill PJ; Eugenin EA; Morgello S; Berman JW
PLoS One; 2013; 8(7):e69270. PubMed ID: 23922698
[TBL] [Abstract][Full Text] [Related]
4. Dopamine Increases CD14
Calderon TM; Williams DW; Lopez L; Eugenin EA; Cheney L; Gaskill PJ; Veenstra M; Anastos K; Morgello S; Berman JW
J Neuroimmune Pharmacol; 2017 Jun; 12(2):353-370. PubMed ID: 28133717
[TBL] [Abstract][Full Text] [Related]
5. Frontline Science: CXCR7 mediates CD14
Veenstra M; Williams DW; Calderon TM; Anastos K; Morgello S; Berman JW
J Leukoc Biol; 2017 Nov; 102(5):1173-1185. PubMed ID: 28754798
[TBL] [Abstract][Full Text] [Related]
6. Dopamine increases CD14+CD16+ monocyte migration and adhesion in the context of substance abuse and HIV neuropathogenesis.
Coley JS; Calderon TM; Gaskill PJ; Eugenin EA; Berman JW
PLoS One; 2015; 10(2):e0117450. PubMed ID: 25647501
[TBL] [Abstract][Full Text] [Related]
7. JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals.
Williams DW; Anastos K; Morgello S; Berman JW
J Leukoc Biol; 2015 Feb; 97(2):401-12. PubMed ID: 25420915
[TBL] [Abstract][Full Text] [Related]
8. CCR2 on CD14(+)CD16(+) monocytes is a biomarker of HIV-associated neurocognitive disorders.
Williams DW; Byrd D; Rubin LH; Anastos K; Morgello S; Berman JW
Neurol Neuroimmunol Neuroinflamm; 2014 Oct; 1(3):e36. PubMed ID: 25340088
[TBL] [Abstract][Full Text] [Related]
9. Characterization of monocyte maturation/differentiation that facilitates their transmigration across the blood-brain barrier and infection by HIV: implications for NeuroAIDS.
Buckner CM; Calderon TM; Willams DW; Belbin TJ; Berman JW
Cell Immunol; 2011; 267(2):109-23. PubMed ID: 21292246
[TBL] [Abstract][Full Text] [Related]
10. Frontline Science: Buprenorphine decreases CCL2-mediated migration of CD14
Jaureguiberry-Bravo M; Lopez L; Berman JW
J Leukoc Biol; 2018 Dec; 104(6):1049-1059. PubMed ID: 29791013
[TBL] [Abstract][Full Text] [Related]
11. Central Nervous System (CNS) Viral Seeding by Mature Monocytes and Potential Therapies To Reduce CNS Viral Reservoirs in the cART Era.
León-Rivera R; Veenstra M; Donoso M; Tell E; Eugenin EA; Morgello S; Berman JW
mBio; 2021 Mar; 12(2):. PubMed ID: 33727362
[TBL] [Abstract][Full Text] [Related]
12. CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection.
Fischer-Smith T; Croul S; Sverstiuk AE; Capini C; L'Heureux D; Régulier EG; Richardson MW; Amini S; Morgello S; Khalili K; Rappaport J
J Neurovirol; 2001 Dec; 7(6):528-41. PubMed ID: 11704885
[TBL] [Abstract][Full Text] [Related]
13. Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-associated neurocognitive disease (HAND).
Ndhlovu LC; Umaki T; Chew GM; Chow DC; Agsalda M; Kallianpur KJ; Paul R; Zhang G; Ho E; Hanks N; Nakamoto B; Shiramizu BT; Shikuma CM
J Neurovirol; 2014 Dec; 20(6):571-82. PubMed ID: 25227930
[TBL] [Abstract][Full Text] [Related]
14. Monocytes mediate HIV neuropathogenesis: mechanisms that contribute to HIV associated neurocognitive disorders.
Williams DW; Veenstra M; Gaskill PJ; Morgello S; Calderon TM; Berman JW
Curr HIV Res; 2014; 12(2):85-96. PubMed ID: 24862333
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the CD14++CD16+ monocyte population in human bone marrow.
Mandl M; Schmitz S; Weber C; Hristov M
PLoS One; 2014; 9(11):e112140. PubMed ID: 25369328
[TBL] [Abstract][Full Text] [Related]
16. Human Blood Monocyte Subsets: A New Gating Strategy Defined Using Cell Surface Markers Identified by Mass Cytometry.
Thomas GD; Hamers AAJ; Nakao C; Marcovecchio P; Taylor AM; McSkimming C; Nguyen AT; McNamara CA; Hedrick CC
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1548-1558. PubMed ID: 28596372
[TBL] [Abstract][Full Text] [Related]
17. Loss of CCR2 expressing non-classical monocytes are associated with cognitive impairment in antiretroviral therapy-naïve HIV-infected Thais.
Ndhlovu LC; D'Antoni ML; Ananworanich J; Byron MM; Chalermchai T; Sithinamsuwan P; Tipsuk S; Ho E; Slike BM; Schuetz A; Zhang G; Agsalda-Garcia M; Shiramizu B; Shikuma CM; Valcour V;
J Neuroimmunol; 2015 Nov; 288():25-33. PubMed ID: 26531691
[TBL] [Abstract][Full Text] [Related]
18. Expansion of a subset of CD14highCD16negCCR2low/neg monocytes functionally similar to myeloid-derived suppressor cells during SIV and HIV infection.
Gama L; Shirk EN; Russell JN; Carvalho KI; Li M; Queen SE; Kalil J; Zink MC; Clements JE; Kallas EG
J Leukoc Biol; 2012 May; 91(5):803-16. PubMed ID: 22368280
[TBL] [Abstract][Full Text] [Related]
19. Statin modulation of monocyte phenotype and function: implications for HIV-1-associated neurocognitive disorders.
Yadav A; Betts MR; Collman RG
J Neurovirol; 2016 Oct; 22(5):584-596. PubMed ID: 27021071
[TBL] [Abstract][Full Text] [Related]
20. Standardization of sampling and sample preparation for analysis of human monocyte subsets in peripheral blood.
Rundgren IM; Bruserud Ø; Ryningen A; Ersvær E
J Immunol Methods; 2018 Oct; 461():53-62. PubMed ID: 29906454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
